Therapeutic gains of prolonged bronchial dilatation in chronic obstructive pulmonary disease

Annals of Internal Medicine

Volumn 143, Issue 5, 2005, Pages 386-387

  Turino, Gerard M ^a,b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; PLACEBO; TIOTROPIUM BROMIDE;

BRONCHODILATATION; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DRUG EFFICACY; FORCED EXPIRATORY VOLUME; HEALTH ECONOMICS; HUMAN; LUNG FUNCTION; PRIORITY JOURNAL; REVIEW; SPIROMETRY; TREATMENT OUTCOME;

EID: 24644442612     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-143-5-200509060-00014     Document Type: Review

References (22)

1. Owings MF, Lawrence L. Detailed diagnoses and procedures, National Hospital Discharge Survey, 1997. Vital Health Stat 13. 1999:1-157. [PMID: 10665293]
2. Hoyert DL, Arias E, Smith BL, Murphy SL, Kochanek KD. Deaths: final data for 1999. Natl Vital Stat Rep. 2001;49:1-113. [PMID: 11591077]
3. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ. 2002;51:1-16. [PMID: 12198919]
4. Pauwels RA, Buist AS, Carverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256-76. [PMID: 11316667]
5. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350: 1005-12. [PMID: 14999112]
6. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106:196-204. [PMID: 3492164]
7. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1418-22. [PMID: 9603117]
8. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest. 2000;117:5S-9S. [PMID: 10673466]
9. Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JA Jr, Korducki L, et al. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator. A randomized trial. Ann Intern Med. 2005;143:317-26.
10. Disse B, Witek TJ Jr. Anticholinergics: tiotropium. In: Hansel TT, Barnes PJ, eds. Progress in Respiratory Research. New Drugs for Asthma, Allergy and COPD. Vol 31. Basel, Switzerland: Karger; 2001:72-6.
11. Maesen FP, Smeets JJ, Sledsens TJ, Wald FD, Cornelissen PJ. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group. Eur Respir J. 1995;8:1506-13. [PMID: 8575576]
12. Carverly PM, Towse LJ, Lee A. The timing of dose and pattern of bronchodilation of tiotropium (TIO) in stable COPD. Eur Respir J. 2000;16:56S.
13. Barr RG, Bourbeau J, Camargo CA, Ram FS. Inhaled tiotropium for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005: CD002876. [PMID: 15846642]
14. Celli B, ZuWallack R, Wang S, Kesten S. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest. 2003;124:1743-8. [PMID: 14605043]
15. Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J. 2002;19:217-24. [PMID: 11866001]
16. Vincken W, van Noord JA, Greefhorst AP, Bantje TA, Kesten S, Korducki L, et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J. 2002;19:209-16. [PMID: 11871363]
17. Waters CM, Sporn PH, Liu M, Fredberg JJ. Cellular biomechanics in the lung. Am J Physiol Lung Cell Mol Physiol. 2002;283:L503-9. [PMID: 12169567]
18. Milic-Emili J. Does mechanical injury of the peripheral airways play a role in the genesis of COPD in smokers? COPD. 2004;1:85-92.
19. Ricard JD, Dreyfuss D, Saumon G. Production of inflammatory cytokines in ventilator-induced lung injury: a reappraisal. Am J Respir Crit Care Med. 2001;163:1176-80. [PMID: 11316656]
20. Vlahakis NE, Schroeder MA, Limper AH, Hubmayr RD. Stretch induces cytokine release by alveolar epithelial cells in vitro. Am J Physiol. 1999;277:L167-73. [PMID: 10409244]
21. Buist AS, Vollmer WM, Sullivan SD, Weiss KB, Lee TA, Menezes AM, et al. The burden of obstructive lung disease initiative (BOLD): rationale and design. Journal of Chronic Obstructive Pulmonary Disease. 2005;2:277-83.
22. Anzueto A, Tashkin D, Menjoge S, Kesten S. One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. Pulm Pharmacol Ther. 2005;18:75-81. [PMID: 15649848]